During the Joint Sessions in WCN'23, partners come together to present their cutting-edge research, innovative technologies, and novel solutions aimed at improving kidney health and advancing patient care. These sessions foster interdisciplinary collaboration, enabling attendees to explore emerging trends, share best practices, and explore potential synergies in nephrology research and clinical practice.
- ISN-SLANH/SAN Joint Session: Chronic Kidney Disease in Disadvantaged Populations in Latin America: Etiology And Complications.
- DICG Session: Financial Neutrality in Organ Donation; Interpreting the Concept and Its Boundaries
- ISN-IPNA Joint Session: Genetics of Glomerular Diseases
- ISN-KDIGO Joint Session: Improving CKD Care From A to Z: A Decade's Perspective After the KDIGO CKD Guideline.
- WKD Session: Kidney Health for All: Preparedness for the Unexpected in Supporting the Vulnerable.
- ISN-TTS Joint Session: Need and Opportunity: Solid Organ Transplantation in Emerging Health Systems.
- WIN / WIN India Special Session: Rising Stars in Nephrology.
- ISN-ASN Joint Session: Stepping Up the Game: New Opportunities to Save Lives of People with Diabetic Kidney Disease.
- ISN-DOPPS Joint Session: The DOPPS Program After 25 Years: Where Are We Heading To?
Key:
Complete
Next
Failed
Available
Locked
ISN-SLANH/SAN Joint Session: Chronic Kidney Disease in Disadvantaged Populations in Latin America: Etiology And Complications.
Open to view video.
Open to view video.
Latin America faces an expanded burden of chronic kidney disease (CKD). On top of the standard causes, the Mesoamerican Nephropathy CKDu epidemic, the Covid pandemic, and social determinants complicate the panorama. In this session we will discuss these factors and present recent evidence from the region.
DICG Session: Financial Neutrality in Organ Donation; Interpreting the Concept and Its Boundaries
Open to view video.
Open to view video.
The Declaration of Istanbul and other global ethics guidance propose the idea of ‘Financial neutrality in organ donation’ and in turn define it to say that donors and their families neither lose nor gain financially as a result of organ donation. What exactly does this mean when translated to the real world? How is this interpreted across the world? When does compensation become inducement? What are or should be the boundaries? The session will explore these issues
ISN-IPNA Joint Session: Genetics of Glomerular Diseases
Open to view video.
Open to view video.
Considering genetic testing accessibility improvement in recent years, it is necessary to understand the significance and indicator of genetic testing application. With the advancement of diagnosis of genetic kidney diseases, new drugs become available, clinical trials are carried out and interventions are performed to delay the decline of kidney function.
ISN-KDIGO Joint Session: Improving CKD Care From A to Z: A Decade's Perspective After the KDIGO CKD Guideline.
Open to view video.
Open to view video.
In the decade following the publication of the KDIGO 2012 CKD guideline, the field of nephrology has witnessed a renaissance in terms of novel approaches towards identifying and treating patients at high risk of CKD progression and adverse outcomes. With the advent of new studies on CKD prognostication and availability of effective therapies that could slow kidney disease progression and complications, this session seeks to advance a more proactive approach of CKD management in which individualized care can be tailored, with the goal of administering the right therapies to the right patients at the right time.
WKD Session: Kidney Health for All: Preparedness for the Unexpected in Supporting the Vulnerable.
Open to view video.
Open to view video.
WKD 2023 theme is Kidney Health for All – Preparing for the unexpected, supporting the vulnerable! This session will focus on how the increase of disastrous event impacts the living conditions of kidney disease patient. It will also assess the needs for society as a whole, including policymakers, health care services, governments, industry, as well as people living with kidney disease and their carers, to be prepared to avoid any disruption in access to diagnosis, treatment, and care.
ISN-TTS Joint Session: Need and Opportunity: Solid Organ Transplantation in Emerging Health Systems.
Open to view video.
Open to view video.
Medical technologies are being disseminated more rapidly than ever to the populations of developing countries, driven by both demand and supply-side factors, and facilitated by knowledge and skills transfer within the medical community. Solid organ transplantation is no exception. Rising incomes, the spread of personal insurance, lifestyle factors adding to the burden of illness, and aging populations mean that demand for treatment for end-stage organ failure is increasing in low and middle-income countries. At the same time, there has been a surge in the volume of available epidemiological data relating to end-stage organ failure and its risk factors. This session will place this new epidemiological data in the health system context, with the objective of conveying the challenges that low- and middle-income countries will face as demand and supply surrounding organ transplantation increase. Finally, using a recently initiated transplantation partnership between transplant centers is Europe, North America and Africa to illustrate the potential for expanding the global scope of transplantation activities, the session would be used to promote collaboration between emerging health systems and physicians and scientists from high-income countries for the purpose of promoting the development of existing solid organ transplant programs.
WIN / WIN India Special Session: Rising Stars in Nephrology.
Open to view video.
Open to view video.
The session celebrates the work of young women nephrologists, the rising stars, who are making an impact with their work in their respective parts of the world. We will discuss a common clinical problem (infection related glomerulonephritis), an area of wide-ranging interest (Cystatin C and eGFR) and challenges faced in developing a transplantation program (ABO incompatible transplantation).
1.Cystatin C in Chronic Kidney Disease This talk discusses the flawed risk-stratification of cardiovascular, cerebrovascular and possibly cancer is currently damaging the health and treatment of our most vulnerable patients. It emphasizes how incorporation of cystatin C testing into our routine assessments may deliver clinically important benefits.
2.Infection associated GN: The term “infection-associated glomerulonephritis” (IRGN) was recently introduced and refers to predominantly bacterial infection causing GN, and the glomerular phenotype is temporally associated with it. IRGN is most commonly seen in developing countries. Worldwide, there are limited studies on the clinical-pathological profile of IRGN and the talk looks into Indian data on this important clinical condition.
3.ABO Incompatible Program in Peru Anace Pastor: The ABO-incompatible living donor kidney transplant (ABOi) allows for an increase in the number of donors and a reduction in the waiting time for those patients who do not have a compatible donor. The speaker discusses the work done and the protocols adapted on ABO-incompatible Kidney Transplantation Program at Peru.
ISN-ASN Joint Session: Stepping Up the Game: New Opportunities to Save Lives of People with Diabetic Kidney Disease.
Open to view video.
Open to view video.
The 21st century has ushered in new ways to detect and treat people with diabetes and chronic kidney disease. This session will describe best practices for detection and treatment. New and powerful medicines to reduce the risk of kidney disease and heart disease for patients with diabetes will be discussed, and strategies to get these treatments to qualifying patients will be described.
ISN-DOPPS Joint Session: The DOPPS Program After 25 Years: Where Are We Heading To?
Open to view video.
Open to view video.
This session will focus on three topics that currently represent important challenges in the management of patients across the spectrum of kidney disease and kidney failure. We will use current DOPPS data to illustrate international practice patterns and variations to discuss unmet needs and suggestions for improvement.
Learning Objectives:
During the session, participants will be able to:
1. Get an update of the current status of the DOPPS program and priority areas of research.
2. Learn about practice variations in the preparation of the transition from CKD to kidney failure.
3. Understand the impact of volume overload and challenges in its management in hemodialysis.
4. Learn about how peritonitis presents in different geographies and how variations in practice influence outcomes.